HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INNOGEN-B

4.080

-0.130-3.09%

Volume:9.61M

Turnover:39.19M

Market Cap:1.86B

PE:-4.43

High:4.230

Open:4.215

Low:4.010

Close:4.210

52wk High:53.000

52wk Low:4.010

Shares:457.00M

HK Float Shares:420.29M

Volume Ratio:0.70

T/O Rate:2.29%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.921

ROE:-36.91%

ROA:-17.30%

PB:1.52

PE(LYR):-4.43

PS:12.16

Loading ...

Overview Company News Filings

INNOGEN-B Shares Drop Over 5% Intraday as Annual Loss Expected to Reach Approximately 341.4 Million Yuan

BRIEF-Guangzhou Innogen Pharmaceutical Expects RMB341.4 Million Loss For Year

Innogen Pharmaceutical Forecasts Wider 2025 Loss

MT Newswires Live

INNOGEN-B Issues Profit Warning, Anticipates 2025 Loss of Approximately RMB 341.4 Million

Guangzhou Innogen expects FY2025 loss of RMB341.4 million

Guangzhou Innogen Pharmaceutical Group Co Ltd - Expected FY Results Due to Increase in Research & Development Expenses of RMB103.3 Mln, Others

THOMSON REUTERS

Guangzhou Innogen Pharmaceutical - Expects RMB341.4 Mln Loss for Year

THOMSON REUTERS

Innogen Pharma Eyes Hong Kong-Listed Share Full Circulation

MT Newswires Live

INNOGEN-B (02591) Plans to Implement H-Share Full Circulation Scheme

Guangzhou Innogen files with CSRC to convert domestic unlisted shares into H shares for Hong Kong listing

INNOGEN-B (02591) Sets 23 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express

INNOGEN-B (02591) Announces February 2026 Monthly Return with No Change in Share Capital

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02591/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"INNOGEN-B","latestPrice":4.08,"timestamp":1787299688008,"preClose":4.21,"halted":0,"volume":9608610,"delay":0,"changeRate":-0.03087885985748216,"floatShares":420285370,"shares":457000000,"eps":-0.9214788014675908,"marketStatus":"Not Yet Opened","change":-0.13,"latestTime":"08-21 16:08:08","open":4.215,"high":4.23,"low":4.01,"amount":39193170,"amplitude":0.052257,"askPrice":4.08,"askSize":55400,"bidPrice":4.07,"bidSize":8200,"shortable":3,"etf":0,"ttmEps":-0.9646366693844273,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":4.21,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.7016963557043266,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-17.30%","roe":"-36.91%","lyrEps":-0.921479,"volumeRatio":0.7016963557043266,"shares":457000000,"dividePrice":0,"high":4.23,"amplitude":0.052257,"preClose":4.21,"low":4.01,"week52Low":4.01,"pbRate":"1.52","psRate":"12.16","week52High":53,"institutionHeld":0,"latestPrice":4.08,"committee":-0.742138,"eps":-0.9214788014675908,"divideRate":0,"volume":9608610,"delay":0,"ttmEps":-0.9646366693844273,"open":4.215,"prevYearClose":30.64,"prevWeekClose":4.08,"prevMonthClose":7.26,"prevQuarterClose":7.09,"fiveDayClose":6.61,"twentyDayClose":7.59,"sixtyDayClose":11.84,"earningDate":1787587200000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02591","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775750400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-08-21","current":-4.227909,"percent":1,"low":-137.156472,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"high":-5.675745,"avg":-45.707081,"sd":29.956855,"marketCap":1863822943},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938},{"date":"2026-03-27","current":-24.701097,"twenty":-78.775514,"median":-59.491697,"eighty":-50.290678,"marketCap":9547524394},{"date":"2026-04-02","current":-24.535908,"twenty":-78.383597,"median":-58.823921,"eighty":-50.052949,"marketCap":9529251620},{"date":"2026-04-10","current":-24.978414,"twenty":-78.348547,"median":-58.584467,"eighty":-49.631191,"marketCap":9775934068},{"date":"2026-04-17","current":-23.474521,"twenty":-78.227102,"median":-58.112982,"eighty":-48.421657,"marketCap":9191205301},{"date":"2026-04-24","current":-19.658213,"twenty":-78.155492,"median":-57.844151,"eighty":-44.116877,"marketCap":7697406030},{"date":"2026-04-30","current":-16.329046,"twenty":-77.825679,"median":-57.660489,"eighty":-41.074266,"marketCap":6395470886},{"date":"2026-05-08","current":-17.822364,"twenty":-77.322024,"median":-57.626503,"eighty":-40.478309,"marketCap":5778764764},{"date":"2026-05-15","current":-17.368107,"twenty":-77.157551,"median":-57.517602,"eighty":-40.012158,"marketCap":5646287153},{"date":"2026-05-22","current":-17.112125,"twenty":-76.782452,"median":-57.446424,"eighty":-25.37304,"marketCap":5550355090},{"date":"2026-05-29","current":-15.607197,"twenty":-76.252433,"median":-57.23775,"eighty":-24.916387,"marketCap":5079831160},{"date":"2026-06-05","current":-14.014909,"twenty":-75.020932,"median":-57.073515,"eighty":-24.414835,"marketCap":4568193490},{"date":"2026-06-12","current":-11.752443,"twenty":-74.621039,"median":-56.924891,"eighty":-23.900197,"marketCap":3828146144},{"date":"2026-06-18","current":-10.549084,"twenty":-74.404407,"median":-56.73827,"eighty":-23.474521,"marketCap":3444417891},{"date":"2026-06-26","current":-9.60263,"twenty":-74.160764,"median":-56.642046,"eighty":-20.865982,"marketCap":3120076153},{"date":"2026-07-03","current":-11.351574,"twenty":-74.088566,"median":-56.533624,"eighty":-19.581214,"marketCap":3691100339},{"date":"2026-07-10","current":-11.238926,"twenty":-74.037218,"median":-56.208644,"eighty":-19.055481,"marketCap":3649986598},{"date":"2026-07-17","current":-10.540302,"twenty":-73.42668,"median":-55.144116,"eighty":-17.753872,"marketCap":3435281504},{"date":"2026-07-24","current":-10.636027,"twenty":-71.947117,"median":-53.621015,"eighty":-17.028947,"marketCap":3467258858},{"date":"2026-07-31","current":-10.1543,"twenty":-71.465685,"median":-51.153424,"eighty":-16.590446,"marketCap":3316508473},{"date":"2026-08-07","current":-10.609247,"twenty":-70.999854,"median":-50.412223,"eighty":-15.817726,"marketCap":3471827052},{"date":"2026-08-14","current":-9.215586,"twenty":-70.625283,"median":-50.222782,"eighty":-14.020929,"marketCap":3019575896},{"date":"2026-08-21","current":-5.675745,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"marketCap":1863822943}],"updateTime":1787508833990},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1163444545","title":"INNOGEN-B Shares Drop Over 5% Intraday as Annual Loss Expected to Reach Approximately 341.4 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1163444545","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163444545?lang=en_us&edition=fundamental","pubTime":"2026-03-20 11:57","pubTimestamp":1773979053,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) fell more than 5% during trading, and as of the latest update, the decline was 2.17%, with the share price at HK$21.62 and a turnover of HK$3.98 million. On March 18, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK4585","02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620232743","title":"BRIEF-Guangzhou Innogen Pharmaceutical Expects RMB341.4 Million Loss For Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620232743?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:53","pubTimestamp":1773831220,"startTime":"0","endTime":"0","summary":"BRIEF-Guangzhou Innogen Pharmaceutical Expects RMB341.4 Million Loss For YearMarch 18  - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK:EXPECTS RMB341.4 MILLION LOSS FOR YEAREXPECTED FY RESULTS DUE TO INCREASE IN RESEARCH & DEVELOPMENT EXPENSES OF  RMB103.3 MILLION, OTHERSFurther company coverage: 2591.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4050WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620383236","title":"Innogen Pharmaceutical Forecasts Wider 2025 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2620383236","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620383236?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:56","pubTimestamp":1773824180,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical  expects a net loss of about 341.4 million yuan for 2025, widening from a loss of about 174.7 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.The pharmaceutical company said the wider loss was mainly due to higher research and development spending and increased selling and distribution expenses related to the product's launch and sales expansion.The company is expected to announce financial results on March 23.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171204323","title":"INNOGEN-B Issues Profit Warning, Anticipates 2025 Loss of Approximately RMB 341.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1171204323","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171204323?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:41","pubTimestamp":1773823269,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that despite generating revenue of approximately RMB 131.5 million in 2025 (2024: zero) following the commercial launch of its core product, Eisupaglutide α, for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620356022","title":"Guangzhou Innogen expects FY2025 loss of RMB341.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620356022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620356022?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:35","pubTimestamp":1773822904,"startTime":"0","endTime":"0","summary":"Innogen expects a loss of about RMB341.4 million for the year ended 31 December 2025, compared with a loss of about RMB174.7 million a year earlier. The company recorded revenue of about RMB131.5 million in 2025, versus nil in 2024, following the commercialization of Efsubaglutide Alfa for type 2 diabetes in China and Macau. Innogen said research and development expenses rose by about RMB103.3 million, driven by higher spending on raw materials, pre-clinical studies, clinical trials and process optimization related to Efsubaglutide Alfa. It also reported an increase in selling and distribution expenses of about RMB174.3 million, mainly due to higher marketing and promotional costs and expanded sales staffing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6NyZPh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620235673","title":"Guangzhou Innogen Pharmaceutical Group Co Ltd - Expected FY Results Due to Increase in Research & Development Expenses of  RMB103.3 Mln, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2620235673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620235673?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:34","pubTimestamp":1773822894,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4050WH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620235627","title":"Guangzhou Innogen Pharmaceutical - Expects RMB341.4 Mln Loss for Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2620235627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620235627?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:34","pubTimestamp":1773822894,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4050WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620242400","title":"Innogen Pharma Eyes Hong Kong-Listed Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2620242400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620242400?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:29","pubTimestamp":1773750578,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical  submitted a filing application for the proposed conversion of all its domestic unlisted shares into Hong Kong-listed shares to the China Securities Regulatory Commission, a Tuesday Hong Kong bourse filing said.The firm also intends to apply for the listing of, and permission to deal in, the converted shares on the Main Board of the Hong Kong Stock Exchange.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172970710","title":"INNOGEN-B (02591) Plans to Implement H-Share Full Circulation Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1172970710","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172970710?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:40","pubTimestamp":1773744032,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on March 17, 2026, the company submitted an application to the China Securities Regulatory Commission for the proposed conversion of all its domestic unlisted shares...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620547425","title":"Guangzhou Innogen files with CSRC to convert domestic unlisted shares into H shares for Hong Kong listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620547425","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620547425?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:37","pubTimestamp":1773743875,"startTime":"0","endTime":"0","summary":"Innogen said it has submitted a filing application for the proposed conversion of all its domestic unlisted shares into H shares. The company plans to apply for the listing of, and permission to deal in, the converted H shares on the Hong Kong Stock Exchange’s Main Board. Innogen said the filing procedures are not yet complete and the implementation plan has not been finalised. It added that no shareholders’ meeting is required to approve the conversion and listing under its articles of association.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL49NV01:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103949350","title":"INNOGEN-B (02591) Sets 23 March 2026 Board Meeting to Approve FY 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1103949350","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103949350?lang=en_us&edition=fundamental","pubTime":"2026-03-10 16:44","pubTimestamp":1773132241,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B, 02591) has scheduled a board meeting for Monday, 23 March 2026. According to the official announcement released in Shanghai on 10 March...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144978709","title":"INNOGEN-B (02591) Announces February 2026 Monthly Return with No Change in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1144978709","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144978709?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:18","pubTimestamp":1772615937,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B, 02591) released its monthly return for the period ended 28 February 2026, confirming no change in its issued share capital composition....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":92,"code":"91000000","status":"200"}]}}